Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > Therma Bright Tweet

<< Previous

Bullboard Posts

Next >>

Comment by wwmeincon Oct 22, 2020 9:25am

107 Views

Post# 31761138

RE:RE:RE:Therma Bright Tweet

RapsAlot wrote: I suppose we can revisit this now instead of waiting until Friday like we agreed. The Tweet was a signal to me.

wwmeinc wrote: Mgmt needed to post this 'fluff' release to "herald" that the gov't of ON is supporting them in their efforts with words?????...Sure thing Raps...seems to points to a mgmt team that is out of their depth and fishing around for anything to raise investor interest in an ocean of fast covid-19 test devices that are real!!!!!

Instead of posting at 11:00pm on a Friday night....{how many reputable firms need to twitter at that hour of Friday night to pump up their shareholder base???} ...Fluffy,twitter nonsense...Why are they not rolling out their "prototype" device to disprove to investors their idea is just not a 'mirage' as the lack of posts referencing anything concrete and backed up with science is disconcerning...4 months with all the "experience" surrounding the company and still no prototype to show to the investment community...maybe Raps you might suggest to mgmt to get real here,real fast!!!;) glta

As a shareholder Raps I am glad to see they have picked a firm to make their product(once they have actually agreed upon all the parts)....great news. No dollar amount attached to this manufacturer...which would have been nice to see if only to provide a bit more transparency to the equation being built here but in the grand scheme of things,it takes money to make money; just something to look out for in the next filing.

"Therma and Orpheus are also pleased to announce the engagement of nanoComposix Inc. to complete the development of CoviSafe. nanoComposix is uniquely positioned to begin final development of CoviSafe, and to assist Therma and Orpheus with defining optimal reagents and chemistries necessary to make CoviSafe an ultrasensitive, rapid, saliva-based, point-of-care lateral flow test for SARS-CoV-2."

I did not and do not see the word working prototype anywhere in this nr...as the above paragraph states,'nanoComposix is hired to help complete the dev. of CoviSafe'...next nr will probably state 'we have a working prototype that will then be submitted to the gov't agencies'....at least Raps this nr is much better than any late night twitter blurp....but I get your gist of the heads-up by the twitter...still investors like to see tangible corporate actions on a corp. letterhead as proof. All in all this is a decent move forward/progression nr...big move will be on the prototype as that is what will be submitted for any approval...good trading and glta.